Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08)
Contributors
Templeton, Arnoud J; Dutoit Vallotton, ValériePublished in
European urology, vol. 64, no. 1, p. 150-158Publication date
2013Abstract
UNIGE affiliation entities
UNIGE research groups
Citation (ISO format)
TEMPLETON, Arnoud J et al. Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08). In: European urology, 2013, vol. 64, n° 1, p. 150–158. doi: 10.1016/j.eururo.2013.03.040
Main files (1)
Article (Published version)
Identifiers
- PID : unige:33771
- DOI : 10.1016/j.eururo.2013.03.040
- PMID : 23582881
